Literature DB >> 4527949

Promotion of fluorescence upon binding of colchicine to tubulin.

B Bhattacharyya, J Wolff.   

Abstract

Colchicine, which does not fluoresce in aqueous media and organic solvents, exhibits marked fluorescence on combination with brain tubulin, with a corrected excitation maximum at 362 nm, an emission maximum at 435 nm, and a quantum yield of about 0.03. From fluorescence measurements it was found that rat brain tubulin binds 0.83 moles of colchicine per dimer (molecular weight 110,000) with an association constant of 3.2 muM(-1) at pH 7.0 and 37 degrees . These results are in excellent agreement with those obtained with the binding of [(3)H]-colchicine. The enthalpy of binding is 10 kcal/mole, with an entropy change of 62 entropy units. The fluorescence can be ascribed to the tropolone moiety. However, the A ring of colchicine is also involved in binding. Denaturing agents abolish fluorescence, whereas podophyllotoxin, another antimitotic agent, decreases fluorescence competitively. Fluorescence is a convenient method for determining the binding of colchicine to tubulin that does not require the separation of free colchicine from bound colchicine and yields values for physical and biochemical parameters that are in excellent agreement with those obtained from the binding of [(3)H]colchicine.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4527949      PMCID: PMC388519          DOI: 10.1073/pnas.71.7.2627

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Spectroscopic determination of tryptophan and tyrosine in proteins.

Authors:  H Edelhoch
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

2.  Vinblastine and griseofulvin reversibly disrupt the living mitotic spindle.

Authors:  S E Malawista; H Sato; K G Bensch
Journal:  Science       Date:  1968-05-17       Impact factor: 47.728

3.  The colchicine-binding protein of mammalian brain and its relation to microtubules.

Authors:  R C Weisenberg; G G Borisy; E W Taylor
Journal:  Biochemistry       Date:  1968-12       Impact factor: 3.162

4.  Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin.

Authors:  L Wilson
Journal:  Biochemistry       Date:  1970-12-08       Impact factor: 3.162

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  Effect of vincristine on the fine structure of HeLa cells during mitosis.

Authors:  P George; L J Journey; M N Goldstein
Journal:  J Natl Cancer Inst       Date:  1965-08       Impact factor: 13.506

7.  Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells.

Authors:  H Wisniewski; M L Shelanski; R D Terry
Journal:  J Cell Biol       Date:  1968-07       Impact factor: 10.539

8.  The mechanism of action of colchicine. Colchicine binding to sea urchin eggs and the mitotic apparatus.

Authors:  G G Borisy; E W Taylor
Journal:  J Cell Biol       Date:  1967-08       Impact factor: 10.539

9.  The mechanism of action of colchicine. Binding of colchincine-3H to cellular protein.

Authors:  G G Borisy; E W Taylor
Journal:  J Cell Biol       Date:  1967-08       Impact factor: 10.539

10.  Cell motility by labile association of molecules. The nature of mitotic spindle fibers and their role in chromosome movement.

Authors:  S Inoué; H Sato
Journal:  J Gen Physiol       Date:  1967-07       Impact factor: 4.086

View more
  36 in total

1.  Polygamain, a new microtubule depolymerizing agent that occupies a unique pharmacophore in the colchicine site.

Authors:  R M Hartley; J Peng; G A Fest; S Dakshanamurthy; D E Frantz; M L Brown; S L Mooberry
Journal:  Mol Pharmacol       Date:  2011-12-14       Impact factor: 4.436

2.  A novel sulfonamide agent, MPSP-001, exhibits potent activity against human cancer cells in vitro through disruption of microtubule.

Authors:  Zu-long Liu; Wei Tian; Yong Wang; Shan Kuang; Xiao-min Luo; Qiang Yu
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

3.  Tubulin aggregation and disaggregation: mediation by two distinct vinblastine-binding sites.

Authors:  B Bhattacharyya; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

4.  4-Amino-5-benzoyl-2-(4-methoxyphenylamino)thiazole (DAT1): a cytotoxic agent towards cancer cells and a probe for tubulin-microtubule system.

Authors:  Suparna Sengupta; Sasidharan L Smitha; Nisha E Thomas; Thankaiyyan R Santhoshkumar; Satyabhama K C Devi; Kumaran G Sreejalekshmi; Kallikat N Rajasekharan
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 5.  Microtubule targeting agents: from biophysics to proteomics.

Authors:  D Calligaris; P Verdier-Pinard; F Devred; C Villard; D Braguer; Daniel Lafitte
Journal:  Cell Mol Life Sci       Date:  2010-01-28       Impact factor: 9.261

6.  Synthesis and Structure-Activity Relationship Study of 1-Phenyl-1-(quinazolin-4-yl)ethanols as Anticancer Agents.

Authors:  Kenta Kuroiwa; Hirosuke Ishii; Kenji Matsuno; Akira Asai; Yumiko Suzuki
Journal:  ACS Med Chem Lett       Date:  2015-01-10       Impact factor: 4.345

7.  Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design.

Authors:  Cristina C Rohena; Nakul S Telang; Chenxiao Da; April L Risinger; James A Sikorski; Glen E Kellogg; John T Gupton; Susan L Mooberry
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

8.  Resistance of Rosa microtubule polymerization to colchicine results from a low-affinity interaction of colchicine and tubulin.

Authors:  L C Morejohn; T E Bureau; L P Tocchi; D E Fosket
Journal:  Planta       Date:  1987-02       Impact factor: 4.116

9.  Novel 9'-substituted-noscapines: synthesis with Suzuki cross-coupling, structure elucidation and biological evaluation.

Authors:  Elena Porcù; Attila Sipos; Giuseppe Basso; Ernest Hamel; Ruoli Bai; Verena Stempfer; Antal Udvardy; Attila Cs Bényei; Helmut Schmidhammer; Sándor Antus; Giampietro Viola
Journal:  Eur J Med Chem       Date:  2014-07-16       Impact factor: 6.514

10.  S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.

Authors:  Chao Zhang; Na Yang; Chun-Hao Yang; Hua-Sheng Ding; Cheng Luo; Yu Zhang; Mao-Jiang Wu; Xiong-Wen Zhang; Xu Shen; Hua-Liang Jiang; Ling-Hua Meng; Jian Ding
Journal:  PLoS One       Date:  2009-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.